Standard BioTools
LAB
68 hedge funds and large institutions have $54.2M invested in Standard BioTools in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 22 reducing their positions, and 11 closing their positions.
28% more capital invested
Capital invested by funds: $42.5M → $54.2M (+$11.7M)
27% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 11
9.5% more ownership
Funds ownership: 49.12% → 58.62% (+9.5%)
5% more funds holding
Funds holding: 65 → 68 (+3)
18% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 22
65% less call options, than puts
Call options by funds: $37K | Put options by funds: $107K
Top Buyers
| 1 |
HBWM
Hollow Brook Wealth Management
Katonah,
New York
|
+$861K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$257K |
| 3 |
Morgan Stanley
New York
|
+$209K |
| 4 |
JCP
Jennifer C. Price
|
+$146K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$61.6K |
Top Sellers
| 1 |
BlackRock
New York
|
-$712K |
| 2 |
Primecap Management
Pasadena,
California
|
-$382K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$293K |
| 4 |
PVI
Pura Vida Investments
New York
|
-$278K |
| 5 |
E
Ergoteles
New York
|
-$220K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BBHC
76
Brown Brothers Harriman & Co
New York
| – | -$3K | -2,307 | Closed |
|
77
Legal & General Group
London,
United Kingdom
| – | -$1K | -1,061 | Closed |
|
|
GKIM
78
GW&K Investment Management
Boston,
Massachusetts
| – | +$142 | +115 | New |
|
|
NA
79
NewEdge Advisors
New Orleans,
Louisiana
| – | +$208 | +169 | New |
|
LAB Hedge Fund Activity: Q4 2022 in Review
68 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q4 2022, worth a combined $54.2M — up 28% from $42.5M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new LAB positions and 11 closed out — a net gain of 3 holders — while 18 added to existing stakes and 22 trimmed.
The largest buyer was Hollow Brook Wealth Management, opening a new position worth an estimated $861K. The largest seller was BlackRock, cutting an estimated $712K.
- 68 institutional investors held Standard BioTools (LAB) as of Q4 2022, up from 65 in Q3 2022.
- Funds reported $54.2M of Standard BioTools stock for Q4 2022, up 28% quarter-over-quarter.
- 14 funds opened new Standard BioTools positions in Q4 2022 and 11 closed out, a net change of +3 holders.
- The largest Standard BioTools buyer in Q4 2022 was Hollow Brook Wealth Management, an estimated $861K added.
- The largest Standard BioTools seller in Q4 2022 was BlackRock, an estimated $712K sold.
Based on aggregated 13F filings for Q4 2022.